Labetalol (versus unexposed) updated on 12-17-2024

Fetal distress

R analysis
id Study   Lib. in paper Exposition period    Study type 
 Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S14353
R56812		 Chan, 2010 Fetal distress during pregnancy (anytime or not specified) prospective cohort unexposed, disease free Adjustment: No Indications Antihypertensive: All hypertensions, any indications or not specified Matched 3.14 [1.01;9.74] C 11/32   6/42 17 32
ref
Total 1 studies 3.14 [1.01;9.74] 17 32
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Chan, 2010Chan, 2010 3.14[1.01; 9.74]17320%ROB confusion: seriousROB selection: moderateROB classification: moderateROB missing: unclearROB mesure: lowROB reporting: moderate0.910.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 3.14[1.01; 9.74]1732 -NAChan, 2010 1 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 3.14[1.01; 9.74]1732 -NAChan, 2010 1 Tags Adjustment   - No  - No 3.14[1.01; 9.74]1732 -NAChan, 2010 1 Indications Antihypertensive   - All hypertensions, any indications ...  - All hypertensions, any indications or not specified 3.14[1.01; 9.74]1732 -NAChan, 2010 1 MatchedMatched 3.14[1.01; 9.74]1732 -NAChan, 2010 1 All studiesAll studies 3.14[1.01; 9.74]1732 -NAChan, 2010 10.510.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 3.14[1.01; 9.74]1732 -NAChan, 2010 10.510.01.0

Umbrella review (other published meta-analyses)

Published MAControlPeriodTE95% CIn exposedkI2 Shekhar (Intravenous labetalol) - GESTATIONAL ...Shekhar (Intravenous labetalol) - GESTATIONAL HYPERTENSION (Fetal heart rate abnormalities) 3.23[0.90; 11.11]NA-Eexposed to other treatment, sickAnyduring pregnancy (anytime or not specified)studies TTT5 metaPregmetaPreg 3.14[1.01; 9.74]NaN%32----Chan, 2010 10.510.01.0